Biological Collection of Brain Tumors

Conditions

• Brain Tumor

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• blood and/or csf collection — BIOLOGICAL
  blood and/or collection Only once : * 1 tube of blood of 4 mL on dry tube with or without gel, * 2 tubes of blood of 4 mL on EDTA tube, If CSF collected for diagnosis is available, it can be sent for storage in the collection.

Study Details

The objective of this study is to build a collection of biological samples from patients with brain tumors.

Key Dates

First listed

Oct 7, 2022

Start date

Nov 22, 2023

Status verified

Jan 2026

Primary completion

Nov 22, 2033

Completion

Nov 22, 2033

Study Design

Enrollment

500 participants (estimated)

Arms

• Arm: brain tumors

Primary Outcome Measure

number of biological samples [ Time Frame: 10 years ]

Central Contacts

• François DUCRAY, Pr
  04 72 68 13 21
  [email protected]
• Apolline Barthelmé
  04 26 73 97 87
  [email protected]

Find similar trials

Related Studies

• Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
  PHASE2 · Recruiting · Northwell Health · New York, New York
• Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
  PHASE1/PHASE2 · Recruiting · Northwell Health · New York, New York
• Study of Letrozole in Recurrent Gliomas
  EARLY_PHASE1 · Recruiting · University of Cincinnati · Cincinnati, Ohio
• APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
  PHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California